(PharmaNewsWire.Com, August 30, 2017 ) Browse 56 Market Data Tables and 38 Figures spread through 157 Pages and in-depth TOC on "Next-Generation Sequencing (NGS) Services Market"
Early buyers will receive 10% customization on this report.
Factors such as factors such as the declining price of sequencing; the high cost of sequencing infrastructure and the need for skilled professionals for efficient NGS sample preparation and analysis; and technological advancements in the field of sequencing are driving the growth of this market.
Sequencing services are also the preferred option for NGS applications with low throughput requirements, which is another major driver for market growth.
The diagnostics segment is expected to hold the largest share of the market in 2017
By applications, the NGS services market is segmented into diagnostics, drug discovery, biomarker discovery, agriculture & animal research, and other applications.
The diagnostics segment accounted for the largest share of the market. The large share of this segment can primarily be attributed to factors such as the growing number of new cancer cases across the globe and technological advancements in NGS-based oncology tests and noninvasive prenatal tests.
Academic & government institutes and research centers are expected to be the fastest-growing end users during the forecast period
By end users, the NGS services market is segmented into academic & government institutes and research centers; hospitals & clinics’; pharmaceutical & biotechnology companies; and other end users. The academic & government institutes and research centers segment is expected to grow at the fastest CAGR. Growing number of NGS based research studies across the globe is expected to drive the growth of this segment.
Geographically, the NGS services market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. North America accounted for the largest share of the market in 2016, followed by Europe.
The large share of North America in this market can primarily be attributed to government support for genomics research, the presence of leading NGS service providers, declining cost of sequencing coupled with the rising awareness of NGS services, and increasing number of NGS-based research & clinical applications in the region.
As of 2016, the major NGS services providers in the global NGS services market included BGI (China), Eurofins Scientific SE (Luxembourg), PerkinElmer, Inc. (U.S.), QIAGEN (Germany), Macrogen Inc. (South Korea), GENEWIZ, Inc. (U.S.), Illumina, Inc. (U.S.), Novogene Corporation (China), GATC Biotech AG (Germany), DNA Link, Inc (South Korea), Genotypic Technology Pvt Ltd (India), LGC Limited (U.K.), Wuxi Apptech Co. Ltd. (China), Zymo Research Corp (U.S.), Source BioScience (U.K.), and Personalis, Inc. (U.S.) among others.
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
